Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns

NCT06653374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26000

Last updated 2024-10-22

No results posted yet for this study

Summary

This study focuses on understanding the conditions that affect newborn health and survival from pregnancy to the first weeks of life at the Isidro Ayora Hospital. The investigators will review data from 2008 to 2022 to identify key factors that may contribute to complications, help improve medical care, and reduce risks for newborns. By doing so, we aim to provide better support to families, healthcare providers, and ensure safer births.

Conditions

  • Preterm Birth
  • Low Birth Weight
  • Intrauterine Growth Restriction (IUGR)
  • Perinatal Asphyxia
  • Neonatal Sepsis
  • Respiratory Distress Syndrome (RDS)
  • Neonatal Jaundice
  • Congenital Malformations
  • Neonatal Hypoglycemia
  • Gestational Diabetes Mellitus (GDM)
  • Placental Abruption
  • Preterm Premature Rupture of Membranes (PPROM)
  • Hypertension, Pregnancy-Induced
  • Pre-Eclampsia

Interventions

BEHAVIORAL

Infant, Premature

This intervention is distinct as it focuses specifically on observational monitoring and evaluation of neonatal outcomes without applying a therapeutic or procedural treatment. Unlike other interventional studies, the emphasis is on analyzing standard care practices, risk factor exposures (e.g., prematurity, maternal complications), and their impact on neonatal morbidity and mortality. The intervention involves systematic data collection and longitudinal follow-up to identify patterns and associations, rather than introducing new clinical techniques or treatment

Sponsors & Collaborators

  • Universidad Central del Ecuador

    collaborator OTHER
  • HOSPITAL GINECO OBSTETRICO ISIDRO AYORA

    lead OTHER

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-12
Primary Completion
2024-09-10
Completion
2024-09-10

Countries

  • Ecuador

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06653374 on ClinicalTrials.gov